Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.
Multiple sclerosis (MS) treatment options have improved significantly over the past decades, but the consequences of MS can still be devastating and the needs for monitoring treatment surveillance are considerable. In the current study we used affinity proteomics technology to identify potential bio...
Main Authors: | Sahl Khalid Bedri, Ola B Nilsson, Katharina Fink, Anna Månberg, Carl Hamsten, Burcu Ayoglu, Ali Manouchehrinia, Peter Nilsson, Tomas Olsson, Jan Hillert, Hans Grönlund, Anna Glaser |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217208 |
Similar Items
-
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study
by: Virginija Danylaité Karrenbauer, et al.
Published: (2021-07-01) -
Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
by: Andrius Kavaliunas, et al.
Published: (2017-01-01) -
Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis
by: Ali Manouchehrinia, et al.
Published: (2018-05-01) -
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
by: Klara Asplund Högelin, et al.
Published: (2021-09-01) -
Tobacco smoking and multiple sclerosis : effects on occurrence, progression and mortality
by: Manouchehrinia, Ali
Published: (2014)